Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Advanced Bladder Cancer × pembrolizumab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 84 Carcinoma, Non-Small-Cell Lung 75 Lung Neoplasms 20 Melanoma 17 Squamous Cell Carcinoma of Head and Neck 16 Triple Negative Breast Neoplasms 11 Stomach Neoplasms 10 Head and Neck Neoplasms 10 Carcinoma, Renal Cell 10 Breast Neoplasms 10 Carcinoma 9 Neoplasms 8 Neoplasm Metastasis 8 Endometrial Neoplasms 7 Urinary Bladder Neoplasms 6 Carcinoma, Hepatocellular 6 Colorectal Neoplasms 5 Carcinoma, Transitional Cell 5 Uterine Cervical Neoplasms 4 Prostatic Neoplasms 4 Esophageal Neoplasms 4 Cholangiocarcinoma 4 Thoracic Neoplasms 3 Skin Neoplasms 3 Respiratory Tract Neoplasms 3 Respiratory Tract Diseases 3 Ovarian Neoplasms 3 Neoplasms by Site 3 Lung Diseases 3 Gallbladder Neoplasms 3

Interventions

pembrolizumab 1 enfortumab vedotin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346053 2026-01-16

Chrono-EVP

British Columbia Cancer Agency

Phase 3 Not yet recruiting

Advanced Bladder Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡